Pieris Pharmaceuticals, Inc.

The current price of PIRS is 0.1450 USD — it has decreased by 6.60% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Pieris Pharmaceuticals, Inc. stocks are traded under the ticker PIRS.

Pieris Pharmaceuticals, Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.

PIRS stock is 12.75% volatile and has beta coefficient of 1.50. Check out the list of the most volatile stocks — is Pieris Pharmaceuticals, Inc. there?

PIRS earnings for the last quarter are −0.18 USD per share, whereas the estimation was −0.18 USD resulting in a 1.88% surprise. The estimated earnings for the next quarter are −0.16 USD per share. See more details about Pieris Pharmaceuticals, Inc. earnings.

Pieris Pharmaceuticals, Inc. revenue for the last quarter amounts to ‪1.94 M‬ USD despite the estimated figure of ‪2.72 M‬ USD. In the next quarter revenue is expected to reach ‪4.02 M‬ USD.

Yes, you can track Pieris Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.

PIRS net income for the last quarter is ‪−4.58 M‬ USD, while the quarter before that showed ‪−10.75 M‬ USD of net income which accounts for 57.37% change. Track more Pieris Pharmaceuticals, Inc. financial stats to get the full picture.

Today Pieris Pharmaceuticals, Inc. has the market capitalization of ‪15.36 M‬, it has decreased by 2.75% over the last week.

No, PIRS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, PIRS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Pieris Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.

PIRS reached its all-time high on Feb 13, 2018 with the price of 9.7500 USD, and its all-time low was 0.1361 USD and was reached on Dec 13, 2023.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has 50.00 employees. See our rating of the largest employees — is Pieris Pharmaceuticals, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Pieris Pharmaceuticals, Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Pieris Pharmaceuticals, Inc. stock shows the sell signal. See more of Pieris Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Pieris Pharmaceuticals, Inc. EBITDA is ‪−14.06 M‬ USD, and current EBITDA margin is −32.85%. See more stats in Pieris Pharmaceuticals, Inc. financial statements.